Depression is a prevalent psychiatric disorder that often leads to poor quality of life and
impaired functioning. Treatment during the acute phase of a major depressive episode aims …

One of the most common inflammatory markers examined in depression is C-reactive
protein (CRP). However, the magnitude of the association between CRP and depression …

The objective of this study was to assess international trends in antipsychotic use, using a
standardised methodology. A repeated cross-sectional design was applied to data extracts …

ObjectiveAlthough monoaminergic-targeted drugs have prompted great advances in the
development of treatments for depression, the need for new options persists, since these …

Objective: Serotonin reuptake inhibitors are the predominant treatment for major depressive
disorder. In recent years, the diversity of the gut microbiota has emerged to play a significant …

Purpose Antidepressant drug use increases worldwide. It is pivotal to closely monitor the
use of antidepressants and to determine in what subpopulations the rise is most substantial …

There is concern that selective serotonin reuptake inhibitor (SSRI) treatment may increase
the risk of suicide attempts or deaths, particularly among children and adolescents …

Purpose To investigate the risk for first depression, assessed as incident hospital contacts
for depression and incident use of antidepressants, among women with breast cancer …

The limited efficacy of available antidepressant therapies may be due to how they affect the
underlying brain network. The purpose of this study was to develop a melancholic MDD …

Introduction. Depression is a major global health problem with a relatively high lifetime
prevalence and significant disability. Antidepressants are the most effective medications …